BE732508A - - Google Patents
Info
- Publication number
- BE732508A BE732508A BE732508DA BE732508A BE 732508 A BE732508 A BE 732508A BE 732508D A BE732508D A BE 732508DA BE 732508 A BE732508 A BE 732508A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR151010 | 1968-05-08 | ||
| FR160292A FR7716M (cs) | 1968-07-23 | 1968-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE732508A true BE732508A (cs) | 1969-10-16 |
Family
ID=26181992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE732508D BE732508A (cs) | 1968-05-08 | 1969-05-05 |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE732508A (cs) |
| DE (1) | DE1923336A1 (cs) |
| GB (1) | GB1217138A (cs) |
| NL (1) | NL6906963A (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR76519B (cs) * | 1981-04-29 | 1984-08-10 | Pfizer | |
| US4728741A (en) * | 1985-01-08 | 1988-03-01 | Smithkline Beckman Corporation | 1-substituted-2-mercapto benzimidazole compounds and intermediates |
-
1969
- 1969-05-05 BE BE732508D patent/BE732508A/xx unknown
- 1969-05-07 NL NL6906963A patent/NL6906963A/xx unknown
- 1969-05-07 DE DE19691923336 patent/DE1923336A1/de active Pending
- 1969-05-07 GB GB2320269A patent/GB1217138A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL6906963A (cs) | 1969-11-11 |
| GB1217138A (en) | 1970-12-31 |
| DE1923336A1 (de) | 1969-11-20 |